2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities.

ObjectiveTo provide evidence-based consensus guidelines for the management of women with cervical cytological abnormalities and cervical cancer precursors.ParticipantsA panel of 121 experts in the diagnosis and management of cervical cancer precursors, including representatives from 29 professional organizations, federal agencies, and national and international health organizations, were invited to participate in a consensus conference sponsored by the American Society for Colposcopy and Cervical Pathology (ASCCP).Evidence and Consensus ProcessGuidelines for the management of women with cervical cytological abnormalities were developed through a multistep process. Starting 6 months before the conference, working groups developed draft management guidelines based on formal literature reviews of English-language articles published in 1988-2001, as well as input from the professional community at large, obtained using interactive Internet-based bulletin boards. On September 6-8, 2001, the ASCCP Consensus Conference was held in Bethesda, Md. Guidelines with supporting evidence were presented and underwent discussion, revision, and voting.ConclusionsManagement of women with atypical squamous cells (ASC) depends on whether the Papanicolaou test is subcategorized as of undetermined significance (ASC-US) or as cannot exclude high-grade squamous intraepithelial lesion (HSIL) (ASC-H). Women with ASC-US should be managed using a program of 2 repeat cytology tests, immediate colposcopy, or DNA testing for high-risk types of human papillomavirus (HPV). Testing for HPV DNA is the preferred approach when liquid-based cytology is used for screening. In most instances, women with ASC-H, low-grade squamous intraepithelial lesion, HSIL, and atypical glandular cells should be referred for immediate colposcopic evaluation.

[1]  Helen H Wang,et al.  Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women , 2001, Cancer.

[2]  M. Hutchinson,et al.  Atypical squamous metaplastic cells , 2001, Cancer.

[3]  G. Friedell,et al.  Adenocarcinoma in situ of the endocervix , 1953, Cancer.

[4]  N. Hardt,et al.  Do Qualifiers of ASCUS Distinguish Between Low- and High-Risk Patients? , 1999, Acta Cytologica.

[5]  L. Koutsky,et al.  Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. , 2000 .

[6]  S. Granter,et al.  Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases. , 1997, American journal of clinical pathology.

[7]  M. Henry,et al.  Atypical cervical cytology. Colposcopic follow-up using the Bethesda System. , 1993, The Journal of reproductive medicine.

[8]  T. Wright,et al.  Precancerous Lesions of the Cervix , 1994 .

[9]  E. Trimble,et al.  Interim Guidelines for Management of Abnormal Cervical Cytology , 1994 .

[10]  J. L. Benedet,et al.  Colposcopic evaluation of abnormal Papanicolaou smears in pregnancy. , 1987, American journal of obstetrics and gynecology.

[11]  R. Zaino,et al.  Variance in the interpretation of cervical biopsy specimens obtained for atypical squamous cells of undetermined significance. , 2000, American journal of clinical pathology.

[12]  M A Kish,et al.  Guide to development of practice guidelines. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  T. Wright,et al.  Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL. , 1998, Journal of Family Practice.

[14]  J. Shim,et al.  Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears. , 1999, Gynecologic oncology.

[15]  R. Hiatt,et al.  Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. , 1999, JAMA.

[16]  V. Wadehra,et al.  A prospective follow up study of women with colposcopically unconfirmed positive cervical smears , 1999, British journal of obstetrics and gynaecology.

[17]  L. Lagasse,et al.  The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population. , 2000, American journal of obstetrics and gynecology.

[18]  D. Spiegelhalter,et al.  Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome , 1992, The Lancet.

[19]  B. Jones,et al.  Quality management in gynecologic cytology using interlaboratory comparison. , 2009, Archives of pathology & laboratory medicine.

[20]  D. Rimm,et al.  Diagnosis of “ASCUS” in women over age 50 is less likely to be associated with dysplasia , 2001, Diagnostic cytopathology.

[21]  M. Tancer,et al.  Abnormal Cervical Cytology in Pregnancy: A 17–Year Experience , 1993, Obstetrics and gynecology.

[22]  J. Kurinczuk,et al.  The "Inconclusive‐Possible high grade epithelial abnormality" category in papanicolaou smear reporting , 1998, Cancer.

[23]  L. Denny,et al.  Does colposcopically directed punch biopsy reduce the incidence of negative LLETZ? , 1995, British journal of obstetrics and gynaecology.

[24]  C. H. Buckley,et al.  A prospective study of conization of the cervix in the management of cervical intraepithelial glandular neoplasia (CIGN)—a preliminary report , 1992 .

[25]  J. T. Cox,et al.  Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. , 1995, American journal of obstetrics and gynecology.

[26]  E. Manna,et al.  Atypical endocervical glandular cells: Accuracy of cytologic diagnosis , 1995, Diagnostic cytopathology.

[27]  M. Read,et al.  Efficacy and safety of large-loop excision of the transformation zone , 1994, The Lancet.

[28]  R. McCarthy.  Magee Women's Hospital. , 1985, Food management.

[29]  G. Orth,et al.  Human Papillomavirus Testing in Women With Mild Cytologic Atypia , 2000, Obstetrics and gynecology.

[30]  M. Quinn,et al.  Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases. , 2000, Gynecologic oncology.

[31]  J. Cangiarella,et al.  Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women , 2001, Cancer.

[32]  N. Joste,et al.  Bethesda classification of cervicovaginal smears: reproducibility and viral correlates. , 1996, Human pathology.

[33]  D. Bell,et al.  Adenocarcinoma In Situ of the Uterine Cervix , 1992, Obstetrics and gynecology.

[34]  C Eskridge,et al.  Cervicography Combined With Repeat Papanicolaou Test as Triage for Low‐Grade Cytologic Abnormalities , 1998, Obstetrics and gynecology.

[35]  Scott B. Cantor,et al.  COLPOSCOPY FOR THE DIAGNOSIS OF SQUAMOUS INTRAEPITHELIAL LESIONS: A META‐ANALYSIS , 1998, Obstetrics and gynecology.

[36]  C. S. Geier,et al.  Clinical evaluation of atypical glandular cells of undetermined significance. , 2001, American journal of obstetrics and gynecology.

[37]  J. H. Bennett,et al.  Should all women with cervical atypia be referred for colposcopy: a HARNET study. Harrisburgh Area Research Network. , 1994, The Journal of family practice.

[38]  L. Massad,et al.  Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. , 2001, Gynecologic oncology.

[39]  David R. Scott,et al.  Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. , 1994, American journal of clinical pathology.

[40]  E. P. Dellinger,et al.  Purpose of Quality Standards for Infectious Diseases , 1994 .

[41]  K. Holmes,et al.  USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  D. Petitti,et al.  The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results. , 1999, American journal of obstetrics and gynecology.

[43]  L. Duska,et al.  Clinical Evaluation of Atypical Glandular Cells of Undetermined Significance on Cervical Cytology , 1998, Obstetrics and gynecology.

[44]  Mark Sherman,et al.  The 2001 Bethesda System: terminology for reporting results of cervical cytology. , 2002, JAMA.

[45]  T. Denehy,et al.  Endocervical Curettage, Cone Margins, and Residual Adenocarcinoma In Situ of the Cervix , 1997, Obstetrics and gynecology.

[46]  C. Crum,et al.  Subclassifying atypical squamous cells in Thin-Prep cervical cytology correlates with detection of high-risk human papillomavirus DNA. , 1999, American journal of clinical pathology.

[47]  L. Tuason,et al.  Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. , 1996, Gynecologic oncology.

[48]  T. Byers,et al.  Prediction of Cervical Intraepithelial Neoplasia Grade 2–3 Using Risk Assessment and Human Papillomavirus Testing in Women With Atypia on Papanicolaou Smears , 2000, Obstetrics and gynecology.

[49]  T. Wright,et al.  Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. , 1998, American journal of obstetrics and gynecology.

[50]  B. Jones,et al.  Follow-up of abnormal gynecologic cytology: a college of American pathologists Q-probes study of 16132 cases from 306 laboratories. , 2000, Archives of pathology & laboratory medicine.

[51]  M. Sherman,et al.  Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. , 2001, American journal of clinical pathology.

[52]  M. Sherman,et al.  Atypical glandular cells of undetermined significance (AGUS): Interobserver reproducibility in cervical smears and corresponding thin-layer preparations. , 2002, American journal of clinical pathology.

[53]  J. Robertson,et al.  Cytological changes preceding cervical cancer. , 1994, Journal of clinical pathology.

[54]  A. Farnsworth,et al.  The Reliability of a Cytological Prediction of Cervical Adenocarcinoma In Situ , 1988, The Australian & New Zealand journal of obstetrics & gynaecology.

[55]  M. Spitzer,et al.  Indications for cone biopsy: pathologic correlation. , 1998, American journal of obstetrics and gynecology.

[56]  C. Redman,et al.  Loop diathermy excision of the cervical transformation zone in patients with abnormal cervical smears. , 1990, BMJ.

[57]  L. Koutsky.  Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. , 2000, Journal of the National Cancer Institute.

[58]  M. Sherman,et al.  The Bethesda System , 1993 .

[59]  C. Holschneider,et al.  A single‐visit cervical carcinoma prevention program offered at an inner city church , 1999, Cancer.

[60]  D. Bell,et al.  Endocervical Glandular Atypia in Papanicolaou Smears , 1992, Obstetrics and gynecology.

[61]  J. Robb.  The “ASCUS” swamp , 1994, Diagnostic cytopathology.

[62]  S. Granter,et al.  Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix , 2001, Cancer.

[63]  J. Robertson,et al.  Risk of cervical cancer associated with mild dyskaryosis. , 1988, BMJ.

[64]  K. Noller,et al.  Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. , 1997, Gynecologic oncology.

[65]  Velarde,et al.  One-Session Management of Cervical Intraepithelial Neoplasia: A Solution for Developing Countries. A Prospective, Randomized Trial of LEEP versus Laser Excisional Conization , 1996, Gynecologic oncology.

[66]  Jones Ba,et al.  Cervical biopsy-cytology correlation. A College of American Pathologists Q-Probes study of 22 439 correlations in 348 laboratories. , 1996 .

[67]  J. Niloff,et al.  Incidence and Predictors of Cervical Dysplasia in Patients With Minimally Abnormal Papanicolaou Smears , 1998, Obstetrics and gynecology.

[68]  A. Valdini,et al.  Incidence and evaluation of an AGUS Papanicolaou smear in primary care. , 2001, The Journal of the American Board of Family Practice.